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Abstract
Background: Metabolic syndrome (MetS) is a cluster of four major obesity-related risk factors for cardiovascular
disease (CVD). Russia has one of the highest CVD mortality in the world, but its association with MetS remains
unknown. Also little is known about factors associated with MetS and its components in Russia.
Methods: Data on 3555 adults aged 18-90 years were collected in a cross-sectional study in 2000. MetS was
defined by the International Diabetes Federation (IDF) and National Cholesterol Education Program (NCEP) criteria.
Sex-specific associations between the IDF-defined MetS, its components, and life-style, socio-economic factors and
laboratory indicators, were analysed using multivariable Poisson regression. Vital status of the study participants was
identified by July 2009. Sex-specific associations between MetS and stroke, Coronary Heart Disease (CHD), CVD and
all-cause death, were studied by Poisson regression adjusted for age, smoking, alcohol and history of CVDs.
Results: After adjustment for all studied factors except BMI, age, serum GGT, C-reactive protein and AST-to-ALT ratio
were associated with MetS in both genders. Additionally, MetS was associated with sedentary lifestyle in women and
with smoking in men. In the same regression model drinking alcohol 2-4 times a month and consumption of five or
more alcohol units at one occasion in men, and drinking alcohol 5 times or more a month in women were inversely
associated with MetS. After a 9-year follow-up, MetS was associated with higher risk of death from stroke (RR = 3.76,
95% CI:1.35-10.46) and from either stroke or myocardial infarction (MI, RR = 2.87, 95% CI:1.32-6.23) in men. No
associations between MetS and any of the studied causes of death were observed in women.
Conclusion: Factors associated with MetS in both genders were age, GGT, C-reactive protein, and AST-to-ALT ratio.
Moderate frequency of alcohol consumption and binge drinking in men and higher leisure time physical activity in
women, were inversely associated with MetS.
Positive associations between MetS and mortality were only observed for deaths from stroke and either stroke or
MI in men.
Background
The metabolic syndrome (MetS) is a cluster of four
major cardiovascular disease (CVD) risk factors; obesity,
insulin resistance (hyperglycemia), arterial hypertension
and dyslipidemia where obesity and insulin resistance
are the core elements [1]. Other important characteris-
tics of MetS include low-grade inflammation, endothelial
dysfunction, plasma hypercoagulability and atherosclero-
sis [2].
MetS is associated with increased CVD and all-cause
mortality [3,4]. Moreover, it may be used as an alterna-
tive to the classic coronary heart disease (CHD) risk
assessment scale such as the Framingham Risk Score
[5]. The prevalence of MetS varies greatly between
countries and ethnic groups [6]. Among Europeans and
white Americans it varies between 20% and 30% with
similar gender distribution [7,8]. Due to its high preva-
lence, MetS is considered as the major public health
problem in Europe, and, particularly in the USA, where
o b e s i t ya n do v e r w e i g h ta r et h es e c o n dl e a d i n gc a u s eo f
preventable death accounting for 300.000 deaths per
year [9].
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demographic, socio-economic, and genetic factors. Age,
body mass index, postmenopausal status, diet rich in
saturated fats, carbohydrates, and smoking have been
positively associated with MetS, while inverse associa-
tions have been shown for physical activity, education,
income, and alcohol intake [7,10-12].
Cardiovascular mortality in Russia is about four times
higher than in Western Europe and the gap is the lar-
gest among middle aged men [13]. Although there is
evidence for a high contribution of hazardous level of
alcohol consumption to high death rates in Russia
[14-16], other factors also need to be investigated. As
MetS represents a cluster of the four of six major cardi-
ovascular risk factors strongly associated with CVD
mortality, one might expect similar high rates of MetS
or its components in Russia.
Despite the fact that determinants of MetS and its
contribution to mortality in Europe and North America
receive much attention by the research community, it
remains one of the least studied factors in Russia. In an
earlier study we showed that while the prevalence of
MetS among Russian women in 2000 was comparable
with findings from other European countries, among
men it was a half of that [17].
The aim of this study was to further explore the data
collected in 2000 by studying socio-demographic and
lifestyle correlates of MetS and associations between the
MetS and CVD-and all-cause mortality after 9 years of
follow-up.
Methods
Study sample
The data were obtained from a cross-sectional popula-
tion-based study conducted in 2000 in Arkhangelsk,
Northwest Russia. Detailed information on study design,
sampling procedure and data collection is presented
elsewhere [17-19]. In brief, we invited 3745 subjects
aged ≥18 years from the patient register at the
Semashko outpatient clinic in Arkhangelsk. Most of the
participants were consecutively recruited when they
came for their obligatory annual medical examinations.
Others, particularly pensioners from the area served by
the Semashko clinic, were specifically invited to partici-
pate in this study. Only 40 individuals refused to partici-
pate (response rate 98.9%).
Data collection
Data on education, occupational status, use of medica-
tions, history of myocardial infarction (MI), diabetes
mellitus, and stroke as well as typical patterns of leisure
time physical activity, smoking, frequency and amount
of alcohol consumption, frequency of fresh fruits and
vegetables intake with no specified time-frames were
collected using a 6-page comprehensive questionnaire.
Blood pressure (BP) was measured three times. The
average of the two last readings was used in the study.
Waist circumference (WC) was measured at the umbili-
cal level. Weight and height were measured with sub-
jects in light clothing and without shoes. Venous blood
samples were drawn and centrifuged within 15-25 min.
Most of the participants fasted prior to testing.
Laboratory analyses
Enzymatic colorimetric tests were used to measure TC
(cholesterol esterase, cholesterol oxidase) and TG (lipo-
protein lipase, glycerokinase, and glycerophosphate oxi-
dase). HDL-C was measured by a homogenous
enzymatic colorimetric test (PEG cholesterol esterase,
and PEG peroxidase). All biochemical analyses of serum
lipids were performed using a Hitachi 737 analyzer.
Gamma-glutamyltransferase (GGT) was measured by an
enzymatic colorimetric test (standardized method,
Roche). Aspartate-aminotransferase (AST) and alanin-
aminotransferase (ALT) were measured photometrically
by Hitachi 917 analyzer. Serum C-reactive protein
(CRP) was measured by particle-enhanced immunotur-
bidimetric assay in a Roche Modular P analyzer (Roche
Diagnostics GmbH, D-68298 Mannheim). Glycated
hemoglobin (HBA1c), which reflects the mean glucose
level over the preceding 2-3 months, was assessed by
Bio-Rad Variant II HPLC system with reagents from
Bio-Rad Laboratories (Inc., Hercules, CA 94547, USA).
The inter-assay and intra-assay coefficients of variation
for all laboratory tests were under 3%.
Definition of the metabolic syndrome
MetS was defined according to the International Dia-
betes Federation (IDF) [6] and National Cholesterol
Education Program (NCEP) [20]criteria. We applied cut-
offs for WC as it was recommended for europids (men
≥94 cm, women ≥80 cm) and (men ≥102 cm, women
≥88 cm), respectively, for IDF and NCEP. We used
HBA1c as the measurement of hyperglycemia (defined
as HBA1c ≥6.1%, and/or self-reported diabetes, and/or
receiving treatment for diabetes).
Description of the variables
Education was divided into 3 categories: low (primary or
secondary school), average (vocational school or incom-
plete university education) and high (complete university
education). As income level was difficult to determine
due to high inflation and collapsing economy due to the
crisis and default in 1998-99, we used data on self-
reported occupational status as a “surrogate” measure
for income. Income level was defined according to offi-
cial data on average salary levels in different sectors of
the economy for year 2000 [21]. Five categories were
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Occasional and daily smokers comprised the group of
smokers, while non-smokers and ex-smokers comprised
the non-smoking group. Leisure-time physical activity
was dichotomized as “inactive” or “sedentary lifestyle”
(predominantly sitting activity like reading, watching
TV) and “active” (walking or bicycling or yard working
at least 4 hours per week, regular training and profes-
sional sport). Intake of fresh fruits or vegetables was
dichotomized as “low” (once a week or less) and “high”
(2 times a week or more). Alcohol consumption was
presented by two variables: frequency of alcohol intake,
and number of alcohol units (AU) consumed on one
occasion. One AU was equal to 13.8 g of pure alcohol.
The frequency of alcohol consumption was divided into
4 groups: abstainers, ≤1 times a month, 2-4 times a
month, ≥5 times a month. The number of AU con-
sumed at one drinking session was divided into 3 cate-
gories: abstainers, 1-4 AU and ≥5 AU (later referred to
as binge drinking). Normal weight, overweight and obe-
sity were defined as a BMI <25, 25-29.9, and ≥30 kg/m
2,
respectively. As the distribution of the liver enzymes
and CRP was right-skewed, we used logarithmically
transformed values in the regression models.
Altogether 150 individuals had missing data on one or
more variables and were excluded from the analyses.
The final sample consisted of 3555 individuals (1918
men and 1637 women) aged 18-90 years or 96% of the
initial sample.
Statistical analyses
Differences in the distribution of the studied characteris-
tics between genders were studied by Pearson’sc h i -
squared tests and unpaired t-tests for categorical and
continuous data, respectively. Gender-specific associa-
tions between MetS defined by the IDF criteria, its indi-
vidual components and socio-demographic, lifestyle and
metabolic factors were calculated using Poisson regres-
sion with robust variance estimates as recommended by
Barros and Hirakata [22], and are presented as crude
and adjusted prevalence ratios (PR) with 95% confidence
intervals (CI).
Follow-up study
In July 2009 we collected data on the vital status of all
study participants, using the mortality register of the
Arkhangelsk Regional Healthcare Department which is
based on data from medical death certificates. Causes of
death were coded using the International Classification
of Diseases, 10th Revision (ICD-10). The study end-
points were: death from coronary heart disease (CHD)
(I20-25); death from stroke (I60-64); death from either
myocardial infarction (MI) or stroke (I21-23; I60-64);
CVD death (I00-99); and all-cause death. By July 2009,
200 subjects of the 3555 participants had died and in 97
of the cases (48%) the diagnosis was verified by autopsy.
To study associations between MetS in 2000 and mor-
tality by 2009, we used both IDF and NCEP definitions
of MetS to increase comparability of the findings with
other studies. Gender-specific risk ratios (RR) were cal-
culated by Poisson regression.
All analyses were performed using STATA 10
(STATA Corp, TX, USA). The study was approved by
the Regional Ethical Committee in Norway.
Results
Sample characteristics
Participants’ background characteristics and the preva-
lence of MetS are presented in Table 1. Men were
younger, had higher income, but lower education than
women. They were more physically active, smoked
more, drank alcohol more often and had higher levels of
alcohol intake at one drinking session. About 50% of the
men reported binge drinking, by contrast to 15% among
women. Vodka/liquor constituted about 66% and 45% of
the total consumption in men and women, respectively
(data not shown). Men also had higher levels of liver
enzymes and CRP. The prevalence of MetS in men was
half of that in women (Table 1).
Correlates of the metabolic syndrome
Among men, MetS was positively associated with age, BMI,
sedentary lifestyle, GGT and CRP; and inversely associated
with income, smoking, frequency and amount of alcohol
intake as well as the AST-to-ALT ratio in the crude analy-
sis. After adjustment for all studied factors except BMI, the
associations between MetS and income disappeared. Addi-
tional adjustment for BMI attenuated most of the associa-
tions except the positive association with age, and inverse
associations with the AST-to-ALT ratio, frequency and
amount of alcohol consumption (Table 2).
In women, MetS was positively associated with BMI,
age, very low income, sedentary lifestyle, GGT and CRP,
and inversely associated with education, unknown
income category, smoking, frequency and amount of
alcohol consumption as well as AST-to-ALT ratio in
crude analysis. After adjustment for all study factors
except BMI, the associations between MetS and income,
education, smoking and alcohol disappeared. After
further adjustment for BMI, only age, sedentary lifestyle,
GGT and CRP remained associated with MetS.
Correlates of the individual metabolic components
In the multivariable analysis of the MetS components
(Table 3), frequency and volume of alcohol intake were
inversely associated with prevalence of hypertriglyceri-
demia (high-TG), low levels of high density lipopro-
teins (low-HDL-C) and hyperglycemia in men. Similar
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Page 3 of 10Table 1 Prevalence of the metabolic syndrome stratified by gender, age, BMI, laboratory tests, socio-demographic and
the life-style characteristics
Socio-demographic and the life-style characteristics Men Women P-value
2
N (%) MetS, % with (95% CI)
1 N (%) MetS, % with (95% CI)
1
Age, years 0.002
18-29 515 (26.9) 1.75 (0.9-3.4) 347 (21.2) 3.8 (2.1-6.5)
30-39 352 (18.4) 6.25 (4.1-9.5) 303 (18.5) 8.6 (5.8-12.5)
40-49 441 (23.0) 11.3 (8.6-14.8) 400 (24.4) 22.8 (18.8-27.2)
50-59 298 (15.5) 14.8 (11.0-19.4) 290 (17.7) 41.4 (35.7-47.3)
60+ 312 (16.3) 18.3 (14.2-23.1) 297 (18.1) 45.5 (39.7-51.3)
BMI, kg/m
2 < 0.001
< 25.0 989 (51.5) 0.3 (0.1-1.0) 781 (47.7) 4.0 (2.8-5.7)
25.0-29.9 707 (36.9) 9.3 (7.4-11.8) 515 (31.5) 28.9 (25.1-33.1)
≥30.0 222 (11.6) 50.9 (44.1-57.6) 341 (20.8) 60.1 (54.7-65.3)
Education < 0.001
Secondary school 435 (22.7) 10.3 (7.7-13.7) 426 (26.0) 31.9 (27.6-36.6)
College 1170(61.0) 7.9 (6.4-9.6) 774 (47.3) 21.3 (18.5-24.4)
University 313 (16.3) 14.4 (10.8-18.9) 437 (26.7) 19.2 (15.7-23.3)
Income < 0.001
Very low 283 (14.8) 17.0 (12.9-22.0) 379 (23.2) 43.8 (38.8-49.0)
Low 136 (7.1) 14.7 (9.4-22.0) 740 (45.2) 20 (17.2-23.1)
Medium 144 (7.5) 6.9 (3.6-12.7) 189 (11.5) 23.8 (18.1-30.7)
High 1058(55.2) 9.3 (7.6-11.2) 34 (2.1) 17.7 (7.4-35.2)
Unknown 297 (15.5) 2.0 (0.8-4.6) 295 (18.0) 6.8 (4.3-10.4)
Sedentary lifestyle < 0.001
Yes 437 (22.8) 14.0 (10.9-17.7) 656 (40.1) 32.2 (28.6-35.9)
No 1481(77.2) 8.2 (6.9-9.7) 981 (59.9) 17.7 (15.4-20.3)
Current smoking < 0.001
Yes 1085(56.6) 7.5 (6.0-9.2) 348 (21.3) 13.2 (9.9-17.3)
No 833 (43.4) 12.1 (10.0-14.6) 1289(78.7) 26.3 (23.9.28.8)
Low fresh fruits/vegetables intake 0.01
Yes 779 (40.6) 8.2 (6.4-10.4) 599(36.6) 25.5 (22.1-29.3)
No 1139(59.4) 10.4 (8.7-12.3) 1038(63.4) 22.4 (19.9-25.0)
Frequency of alcohol intake < 0.001
Abstainers 230 (12.0) 15.2 (11.0-20.7) 445 (27.2) 34.2 (29.8-38.8)
≤ 1 times a month 434 (22.6) 12.4 (9.6-16.0) 542 (33.1) 25.3 (21.7-29.2)
2-4 times a month 979 (51.0) 7.2 (5.7-9.0) 571 (34.9) 15.9 (13.1-19.3)
≥5 times a month 275 (14.3) 8.4 (5.5-12.4) 79 (4.8) 6.3 (2.4-14.8)
Number of AU on occasion < 0.001
Abstainers 230 (12.0) 15.2 (11.0-20.7) 445 (27.2) 34.2 (29.8-38.8)
1-4 AU 780 (40.5) 9.5 (7.6-11.8) 946 (57.7) 20.0 (17.5-22.7)
≥ 5 AU 912 (47.5) 8.0 (6.4-10.0) 248 (15.1) 17.7 (13.3-23.2)
Self-reported
MI or stroke
56 (2.9) 51 (3.1) 0.768
GGT, U/l, mean (SD) 43.7 (60.8) 28.4 (39.8) < 0.001
AST, U/l, mean (SD) 29.5 (22.7) 23.6 (13.7) < 0.001
ALT, U/l, mean (SD) 20.7 (20.8) 12.9 (12.8) < 0.001
AST/ALT, mean (SD) 1.8 (0.9) 2.1 (0.8) < 0.001
CRP, mg/l, mean (SD) 3.2 (9.1) 2.6 (5.6) 0.02
Metabolic syndrome
3 182/1918 9.5 (8.2-10.9) 385/1637 23.5 (21.5-25.7) < 0.001
1 95% CI for proportions calculated using Wilson procedure
2 p-values for the differences between genders
3 Metabolic syndrome defined according to the modified IDF criteria
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tion in women. The volume of consumed alcohol
increased HDL-C levels, but showed weaker associa-
tion in women than in men. Current smoking in men
and sedentary lifestyle in women, were related to unfa-
vorable lipid status. It was associated with 40% lower
rates of central adiposity in men, as compared to non-
smokers.
Serum levels of GGT and CRP in women were positively
related to all five metabolic components (Table 3). High
serum levels of GGT were the strongest metabolic marker
in men, in whom it was related to increased prevalence of
Table 2 Sex-specific crude and multivariate adjusted PRs for metabolic syndrome¹
Factor Men Women
Model 1
2 Model 2 Model 3 Model 1
2 Model 2 Model 3
Age
18-29 Reference Reference Reference Reference Reference Reference
30-39 3.58 (1.67-7.68) 2.24 (0.82-6.18) 1.4 (0.57-3.43) 2.29 (1.20-4.38) 1.55 (0.80-2.98) 1.42 (0.78-2.58)
40-49 6.49 (3.23-13.04) 3.75 (1.44-9.78) 2.03 (0.88-4.68) 6.07(3.46-10.67) 3.43 (1.90-6.19) 2.50 (1.45-4.33)
50-59 8.45 (4.18-17.06) 4.98 (1.89-13.14) 2.91 (1.25-6.75) 11.1(6.37-19.16) 5.39 (2.93-9.89) 3.76 (2.12-6.67)
60+ 10.45 (5.25-20.82) 6.58 (2.34-18.49) 5.06 (2.09-12.21) 12.1(7.02-20.98) 5.09 (2.69-9.65) 3.97 (2.17-7.26)
P for trend < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
Education
Secondary school Reference Reference Reference Reference Reference Reference
College 0.76 (0.54-1.07) 1.03 (0.73-1.47) 1.23 (0.86-1.76) 0.67 (0.55-0.81) 0.96 (0.78-1.18) 0.89 (0.73-1.09)
University 1.39 (0.94-2.05) 1.10 (0.73-1.65) 1.18 (0.79-1.77) 0.60 (0.48-0.76) 0.80 (0.62-1.03) 0.89 (0.69-1.13)
P for trend 0.190 0.660 0.375 < 0.001 0.085 0.329
Income
Very low 1.15 (0.71-1.86) 0.87 (0.48-1.59) 0.81 (0.46-1.44) 2.19 (1.82-2.63) 0.99 (0.77-1.26) 0.97 (0.76-1.23)
Low Reference Reference Reference Reference Reference Reference
Medium 0.47 (0.23-0.97) 0.67 (0.32-1.40) 0.62 (0.28-1.33) 1.19 (0.89-1.60) 1.11 (0.82-1.50) 1.03 (0.75-1.41)
High 0.62 (0.40-0.98) 0.84 (0.52-1.33) 0.81 (0.50-1.31) 0.88 (0.42-1.85) 0.97 (0.47-1.98) 1.01 (0.53-1.92)
Unknown 0.14 (0.06-0.33) 0.83 (0.26-2.62) 1.22 (0.45-3.31) 0.34 (0.22-0.53) 0.69 (0.45-1.07) 0.79 (0.52-1.19)
Fresh fruits/vegetab. intake; high vs. low 1.26 (0.94-1.69) 1.21 (0.90-1.63) 1.17(0.85-1.58) 0.88 (0.73-1.05) 1.05 (0.88-1.25) 1.06 (0.90-1.25)
Current smoking 0.62 (0.47-0.81) 0.74 (0.56-0.97) 1.08 (0.81-1.45) 0.50 (0.38-0.67) 0.98 (0.74-1.30) 1.04 (0.80-1.35)
Sedentary lifestyle 1.7 (1.28-2.28) 1.33 (0.99-1.81) 1.13 (0.84-1.52) 1.81 (1.52-2.16) 1.31 (1.11-1.55) 1.19 (1.01-1.40)
Frequency of alcohol intake
Abstainers Reference Reference Reference Reference Reference Reference
≤1 times a month 0.82 (0.55-1.21) 0.90 (0.60-1.35) 0.66 (0.45-0.98) 0.74 (0.61-0.90) 1.13 (0.92-1.39) 1.04 (0.85-1.27)
2-4 times a month 0.47 (0.32-0.67) 0.62 (0.42-0.93) 0.59 (0.41-0.85) 0.47 (0.37-0.59) 0.96 (0.75-1.22) 0.90 (0.71-1.14)
≥5 times a month 0.55 (0.33-0.90) 0.76 (0.46-1.26) 0.61 (0.37-1.00) 0.19 (0.08-0.44) 0.42 (0.19-0.97) 0.58 (0.26-1.30)
P for trend < 0.001 0.045 0.030 < 0.001 0.202 0.190
Body Mass Index
< 25 Reference Reference Reference Reference Reference Reference
25.0-29.9 30.78 (9.71-97.51) - 22.0 (6.61-73.24) 7.3 (5.0-10.6) - 4.4 (3.0-6.5)
30.0-34.9 163.1(52.2-509.6) - 105.0 (31.6-349.1) 14.5 (10.1-20.9) - 7.0 (4.6-10.5)
≥35 195.7 (61.0-628.1) - 132.9 (39.1-451.5) 16.8 (11.5-24.5) - 7.3 (4.8-11.3)
Number of AU on one occasion
3
Abstainers Reference Reference Reference Reference Reference Reference
1-4 AU 0.61 (0.42-0.89) 0.78 (0.53-1.15) 0.69 (0.48-0.99) 0.58 (0.49-0.70) 1.04 (0.85-1.26) 0.96 (0.79-1.17)
≥ 5 AU 0.52 (0.36-0.75) 0.61 (0.40-0.93) 0.52 (0.35-0.76) 0.52 (0.38-0.70) 1.07 (0.79-1.46) 1.06 (0.78-1.43)
P for trend 0.003 0.017 0.001 < 0.001 0.631 0.893
Log GGT 4.3 (3.18-5.81) 1.83 (1.22-2.75) 1.28 (0.82-2.0) 4.08 (3.28-5.07) 1.69 (1.27-2.26) 1.62 (1.22-2.15)
Log AST/Log ALT 0.11 (0.05-0.27) 0.09 (0.04-0.22) 0.19 (0.08-0.46) 0.34 (0.21-0.56) 0.56 (0.33-0.94) 0.82 (0.51-1.32)
Log CRP 2.28 (1.9-2.73) 1.63 (1.28-2.09) 1.27 (0.93-1.72) 3.16 (2.73-3.65) 2.17 (1.82-2.59) 1.61 (1.09-1.12)
1 Metabolic syndrome is defined according to modified IDF criteria.
2 Model 1: crude PRs. Model 2 estimates for the MetS adjusted for age, education, income, frequency of fresh fruit and vegetable intake, smoking habits, physical
activity and the frequency of alcohol consumption. Model 3: estimates for the MetS adjusted for all covariates in Model 2 plus BMI.
3 The PRs for “Number of AU on one occasion” in Model 2 and Model 3 adjusted as before excluding variable “Frequency of alcohol consumption”.
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The AST-to-ALT ratio was inversely associated with
hypertriglyceridemia and central obesity in both genders,
although the strength of association was larger in men.
Metabolic syndrome and mortality
MetS as defined by the IDF criteria was associated with
more than 6 times higher risk of death from stroke
among men after 9 years of observation in (Table 4,
Model 1). Adjustment for age, history of CVD, smoking
and alcohol attenuated the association, but the risk of
death from stroke was still more than 3 times higher for
men with MetS. Death from either stroke or myocardial
infarction occurred twice as common among the men
with IDF-defined MetS (Model 3). In women, the asso-
ciation between MetS and death from the former causes
was much less pronounced (Model 1) and disappeared
after adjustment for other covariates.
The risk of cardiovascular death was almost 2.5 times
higher both in men and women with MetS (Table 4,
Table 3 Gender-specific multivariable adjusted PRs¹ for individual components of the metabolic syndrome defined
according to modified IDF criteria by frequency and volume of alcohol consumption, other life-style factors, levels of
GGT, AST-to-ALT ratio and C-reactive protein
Metabolic abnormalities
High TG Low HDL-C Central obesity
2 Hypertension Hyperglycemia
Men (1918)
Frequency of alcohol intake
Never Reference Reference Reference Reference Reference
1 time a month 0.85(0.65-1.12) 0.94(0.75-1.18) 1.11(0.83-1.49) 1.01(0.90-1.14) 0.52(0.26-1.02)
2-4 times a month 0.76(0.59-0.97) 0.80(0.65-0.98) 0.95(0.71-1.26) 0.96(0.86-1.08) 0.59(0.33-1.05)
≥5 times a month 1.02(0.76-1.36) 0.85(0.64-1.12) 0.89(0.62-1.29) 0.97(0.83-1.13) 0.42(0.13-1.37)
P for trend 0.743 0.059 0.243 0.410 0.090
Number of AU on one occasion
3
Abstainers Reference Reference Reference Reference Reference
1-4 AU 0.90(0.71-1.16) 0.86(0.70-1.06) 1.00(0.76-1.33) 0.97(0.87-1.09) 0.56(0.30-1.02)
≥5 AU 0.73(0.57-0.95) 0.79(0.63-0.98) 0.96(0.71-1.29) 0.96(0.86-1.08) 0.50(0.27-0.95)
P for trend 0.005 0.034 0.682 0.603 0.053
Current smoking 1.12(0.95-1.33) 1.25(1.07-1.46) 0.61(0.50-0.74) 0.95(0.87-1.03) 0.87(0.52-1.46)
Sedentary lifestyle 0.98(0.82-1.19) 1.11(0.93-1.31) 1.17(0.96-1.44) 1.04(0.95-1.15) 1.14(0.69-1.90)
LogAST-to-LogALT 0.39(0.22-0.67) 0.90(0.62-1.32) 0.19(0.11-0.33) 1.14(0.95-1.37) 0.82(0.22-3.04)
Log GGT 2.32(1.80-2.98) 0.80(0.59-1.08) 1.78(1.32-2.40) 1.21(1.05-1.40) 1.45(0.68-3.07)
Log CRP 0.92(0.76-1.11) 1.52(1.33-1.75) 1.57(1.30-1.89) 1.00(0.91-1.10) 1.51(0.95-2.41)
Women (1637)
Frequency of alcohol intake
Never Reference Reference Reference Reference Reference
1 time a month 0.96(0.76-1.22) 0.90(0.78-1.04) 1.12(1.00-1.26) 0.96(0.85-1.09) 1.0(0.57-1.75)
2-4 times a month 0.83(0.63-1.10) 0.75(0.64-0.88) 1.03(0.91-1.18) 0.96(0.82-1.12) 0.42(0.17-1.04)
≥5 times a month 0.52(0.25-1.09) 0.48(0.32-0.72) 0.75(0.52-1.08) 0.76(0.45-1.30) -
P for trend 0.065 < 0.001 0.605 0.346 0.030
Number of AU on one occasion
3
Abstainers Reference Reference Reference Reference Reference
1-4 AU 0.88(0.71.1.11) 0.82(0.71-0.94) 1.06(0.95-1.18) 0.94(0.84-1.06) 0.77(0.44-1.35)
≥5 AU 0.98(0.70-1.37) 0.84(0.69-1.02) 1.15(0.98-1.36) 1.03(0.84-1.27) 0.79(0.28-2.20)
P for trend 0.684 0.039 0.087 0.915 0.442
Current smoking 1.40(1.08-1.82) 1.16(1.0-1.35) 0.94(0.81-1.09) 0.87(0.71-1.08) 1.08(0.37-3.18)
Sedentary lifestyle 1.24(1.03-1.50) 1.11(0.99-1.25) 1.06(0.97-1.16) 0.96(0.87-1.06) 0.98(0.60-1.60)
LogAST-to-LogALT 0.55(0.31-0.99) 1.17(0.88-1.55) 0.51(0.37-0.68) 0.92(0.70-1.21) 0.78(0.21-2.96)
Log GGT 1.93(1.42-2.62) 1.25(1.01-1.55) 1.27(1.08-1.50) 1.19(0.98-1.44) 2.18(0.99-4.83)
Log CRP 1.49(1.21-1.82) 1.42(1.25-1.61) 1.68(1.51-1.86) 1.29(1.14-1.45) 1.98(1.27-3.07)
1 The regression models are adjusted for: age, intake of fresh fruits or vegetables, level of leisure time physical activity, income, education, smoking, frequency of
alcohol intake and body mass index (BMI).
2 PRs for central obesity are given for the regression model excluding BMI.
3 PRs for “Number of alcohol units (AU) on one occasion” are given for the regression model excluding “Frequency of alcohol intake”.
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Page 6 of 10Model 1). However, in both genders these associations
disappeared after adjustment for age, and reduced even
further after adjustment for other factors. Similar asso-
ciations were found between all-cause death and MetS
in crude analysis, but were attenuated after adjustment
for age. The adjusted risk ratio for women was about
40% higher, but did not reach the level of statistical sig-
nificance (Model 3). No consistent associations between
CHD death and MetS were found. Associations between
mortality and MetS defined by the NCEP criteria were
in the same direction.
Discussion
T ot h eb e s to fo u rk n o w l e d g et h i si st h ef i r s ts t u d yi n
Russia on determinants of MetS and its association with
all-cause and cardiovascular mortality. The main findings
suggest that frequency of alcohol consumption and
amount of alcohol consumed at one drinking episode are
important correlates of MetS in Northwest Russia. Age,
sedentary lifestyle and liver enzymes were also associated
with MetS independently of all other studied factors.
Moreover, MetS was associated with increased risk of
death from stroke and either stroke or myocardial
infarction among men during the 9-year observation per-
iod. The study discloses sex-specific adjusted relation-
ships between frequency and volume of alcohol
consumption in Russia (where these factors are consid-
ered to be very important correlates [15,16,23] of cardio-
vascular death) and all other major cardiovascular risk
factors (except smoking) taken both individually and in
frames of the MetS concept. GGT, AST, ALT and, parti-
cularly, C-reactive protein and AST-to-ALT ratio were
associated with MetS and its individual components as
expected from the current knowledge [2,24-27].
However, the results should be interpreted cautiously
taking into account several limitations of the study.
Unemployed and marginalized subjects are likely to be
underrepresented. There were 150 participants with
missing data on one or several characteristics, although,
they did not differ systematically from those included in
the analyses by characteristics for which the data were
available. Application of modified IDF and NCEP cri-
teria where we used HBA1c serum levels instead of
plasma glucose could result in some underestimation of
t h ep r e v a l e n c eo fM e t S ,s i n c et h eH B A 1 ci sl e s ss e n s i -
tive. Other limitations related to study design including
Table 4 Risk ratios (RR) with 95% confidence intervals (CI) for death from CHD, stroke, myocardial infarction or stroke,
CVD and all causes associated with metabolic syndrome during the 9-year follow-up
RR (95% CI)
Models
1 Men (1918) Women (1637)
IDF NCEP IDF NCEP
N (%) 182 (9.5) 191 (10.0) 385 (23.5) 343 (21.0)
CHD death, N 44 18
Model 1 1.84(0.81-4.18) 1.74(0.76-3.95) 1.64(0.61-4.39) 3.07(1.20-7.83)
Model 2 0.97(0.41-2.26) 0.87(0.37-2.03) 0.99(0.34-2.94) 1.53(0.54-4.34)
Model 3 0.78(0.32-1.91) 0.73(0.30-1.76) 0.86(0.27-2.67) 1.45(0.49-4.33)
Stroke death, N 15 17
Model 1 6.36(2.29-17.67) 7.91(2.90-21.58) 1.77(0.66-4.77) 2.64(1.01-6.89)
Model 2 3.32(1.25-8.83) 4.07(1.55-10.72) 0.95(0.36-2.53) 1.23(0.48-3.14)
Model 3 3.16(1.11-9.00) 3.76(1.35-10.46) 0.92(0.36-2.33) 1.18(0.48-2.90)
Stroke/MI death, N 25 23
Model 1 4.49 (1.96-10.26) 6.03 (2.75-13.23) 1.15 (0.46-2.89) 2.01 (0.86-4.71)
Model 2 2.40 (1.09-5.31) 3.12 (1.45-6.73) 0.63 (0.25-1.56) 0.92 (0.40-2.11)
Model 3 2.22 (1.02-4.94) 2.87 (1.32-6.23) 0.60 (0.25-1.43) 0.89 (0.40-1.97)
CVD death, N 66 42
Model 1 2.34(1.30-4.21) 2.66(1.53-4.64) 2.00(1.09-3.69) 3.43(1.89-6.21)
Model 2 1.25(0.73-2.15) 1.38(0.83-2.28) 1.11(0.63-1.96) 1.58(0.91-2.73)
Model 3 1.08(0.64-1.82) 1.23(0.76-2.00) 1.09(0.63-1.89) 1.54(0.91-2.61)
All-cause death, N 124 76
Model 1 1.41(0.86-2.34) 1.95(1.26-3.02) 2.12(1.36-3.31) 2.90(1.87-4.49)
Model 2 0.80(0.51-1.27) 1.07(0.71-1.59) 1.15(0.76-1.72) 1.40(0.94-2.09)
Model 3 0.76(0.48-1.18) 1.01(0.69-1.49) 1.13(0.76-1.68) 1.38(0.94-2.04)
1Model 1 presents crude estimates.
Model 2 presents data adjusted for age.
Model 3 presents data adjusted for age, history of cardiovascular diseases, smoking status and alcohol intake (number of AU taken on one occasion).
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elsewhere [17-19]. Given that diabetes is a risk factor for
CVD, the sample was re-analyzed without those who
reported diabetes in 2000, but the results were virtually
identical.
During the 9-year follow-up we were not able to dif-
ferentiate those who died in other regions and those
who migrated, but did not die. This problem can be
attributed to virtually all large Russian longitudinal stu-
dies, since there is no national population and mortality
registers available for medical research. As a result, the
participants, who moved from the Arkhangelsk region
during the period of observation, could not be traced
and those who died outside the region couldn’t be regis-
tered. The approximate estimates of loss due to migra-
tion during the 9-year period is estimated to be between
15 and 17.5% [28]. Young people (≤30 years) were more
likely to migrate to other regions, presumably looking
for better work or education. Cardiovascular mortality
in this age-group was lowest, compared to the other
age-groups, and deaths from external causes accounted
for more than 75%. Therefore, it seems unlikely that
this loss to follow-up strikingly affected the observed
associations between MetS and CVD mortality.
Both frequency of alcohol drinking and amount of
alcohol consumed on one occasion were inversely asso-
ciated with MetS, particularly among men. Interestingly,
the crude association between the amount of alcohol
consumed on one occasion and MetS was similar for
men and women. However, after adjustment, the asso-
ciation persisted only among men. This association
seems to be mediated by favorable changes in the lipid
profile, but also by improvements in insulin action and
lower risk for hyperglycemia (Table 3). A consumption
of five or more AU on occasion (about ≥75 g of ethanol)
was independently related to 50% lower prevalence of
MetS (Table 2, Model 3), and, respectively, 25, 20 and
50% lower prevalence of hypertriglyceridemia, low-HDL-
C levels and hyperglycemia (Table 3) among men.
Moderate alcohol consumption is known to increase
serum triglycerides level, mainly because of alcohol-sti-
mulated lipolysis [29]. There is evidence that a large part
of this TG increase is mediated by contemporary fat con-
sumption [30]. In western communities alcohol intake is
often moderate and followed by affluent ingestion of
foods, rich in polyunsaturated fats, whereas Russian men
still widely combine a pattern of vodka binge drinking
with low food intake [15,31]. These cultural peculiarities
may explain the decrease of the TG level in response to
higher amounts of alcohol consumed among Russian
men. Taking into account that more than 50% of men in
the study sample reported that they drink at least 5 AU
(about one 200 ml glass of vodka) on occasion, and two
thirds reported intake of mainly vodka at least two times
a month (much the same findings were reported in other
studies [32,33] from Russia), we consider that the life-
style associated with such a pattern of alcohol intake
plays an important role in metabolic risk reduction
among Russian men. Thus, gender-specific pattern of
alcohol intake and the type of alcohol consumed (high
single occasion consumption of strong alcohol by men)
together with a confirmed effect of alcohol on serum
lipids and insulin resistance might at least partly explain
lower rates of MetS among men. It is also possible that
this mechanism might also explain the lower metabolic
risk in Russian men compared to their Western counter-
parts. Higher metabolic risk among subjects who
abstained from alcohol relative to moderate drinkers, has
also been described in longitudinal [34] and cross-sec-
tional [10,35,36] studies. Our results are in line with
these findings, suggesting that the pattern of alcohol con-
sumption we found, improves the lipid spectrum by
increasing the HDL-C concentration and lowering the
low-density lipoprotein cholesterol (LDL-C). Similar
results were obtained in another study from Russia where
the levels of HDL-C and LDL-C were, respectively,
directly and inversely associated with alcohol consump-
tion[37]. Our finding that a consumption of ≥5A Uo n
occasion is associated with improved glycemic profile,
possibly, due to reduction of the insulin resistance, agrees
also well with the existing knowledge [29,38].
Low education and low income has been consistently
associated with MetS in the US [7,34]. In our study we
found no clear effect of these factors. In crude analysis
we found slightly lower prevalence of MetS in women
with university education and in men with high income.
This association disappeared after adjustment. This dis-
crepancy with the findings from other countries may be
due to the fact that in Russia the distribution of health
outcomes is less strongly linked to socio-economic sta-
tus compared to the US or the UK. Higher education in
Russia does not guarantee high socio-economic status.
Moreover, subjects included in the high income category
were relatively poor by international standards with an
average monthly salary of about 500 USD.
Several studies have reported sedentary life-style as a
risk factor for MetS [7,11,12]. We also observed that
low leisure-time physical activity was associated with
higher prevalence of MetS in both genders, indepen-
dently of other studied factors.
We observed an inverse association between smoking
and MetS (crude analysis), but this association disap-
peared after adjustment. However, smoking was posi-
tively associated with dyslipidemia in both genders and
inversely with central adiposity in men. These findings
are consistent with previous research suggesting that
nicotine increases the energy expenditure, reduces the
appetite and stimulates the lipolysis, thus decreasing the
Sidorenkov et al. BMC Public Health 2010, 10:582
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Page 8 of 10risk for obesity [39]. On the other hand, smoking nega-
tively affects the coronary heart system through elevation
of blood pressure and development of arteriosclerosis.
Increased serum levels of GGT, CRP and low AST-to-
ALT ratio turned out to be independently associated
with high metabolic risk, similarly to what has been
observed in previous research[2,24-26]. The association
of GGT and CRP with MetS was stronger in women,
whereas the effect of AST-to-ALT ratio was more pro-
nounced in men (Model 3, Table 2). Several studies
have reported that both GGT and CRP synergistically
increase with the risk of both metabolic syndrome and
obesity as well as with a high alcohol intake [24,25,40].
The pattern of association of the AST-to-ALT ratio is
totally different; the ratio tends to be lower (often ≤1) in
obese and subjects with the MetS, and higher (often ≥2)
in those with high alcohol consumption [27]. One possi-
ble explanation of this gender difference is that the asso-
ciation of BMI with MetS in men was much stronger.
Another explanation is that the adjusted effects of AST-
to-ALT ratio constitute a proxy of the protective action
of alcohol which was not fully reflected by self-report
[19]. This effect is not evident for GGT and CRP since
they are synergistically related to both MetS and alcohol
consumption, but it is apparent for the AST-to-ALT
ratio (antagonistic association). This suggests that the
gender-dependent strength of association for GGT and
CRP levels and the AST-to-ALT ratio with MetS and its
individual components underlines the protective effect
of alcohol intake on MetS we found in our study.
MetS was associated with an increased risk of stroke-,
either stroke or MI-, CVD-and all-cause death during
the 9 year follow-up. After adjustment for age and other
potential confounders, the risk was still more than 3
times higher for a fatal stroke and more than 2 times
higher for death from either stroke or MI among men
with MetS. The lack of significant associations between
MetS and, CVD-, and, particularly, CHD-death in the
adjusted analyses, might be due to heterogeneity of
these diagnostic groups. The CHD, for example,
included not only diagnoses of fatal myocardial infarc-
tion (I21-23) which are clinically well-distinguishable,
characterized by progressing atherosclerosis and patho-
genetically close to relatively homogenous and clinically
well-defined group of cerebral strokes (I60-I64), but also
such vaguely defined conditions as “other forms of acute
or sub-acute ischemia” (I24) and “chronic ischemic
heart disease” (I25). The latest evidences from Russia
suggest that alcohol is an important factor implicated in
the pathophysiology of the former two causes of death,
and that some deaths within these subgroups are actu-
ally caused by acute alcohol intoxication[16] or alcoholic
cardiomyopathy due to chronic toxic effects of alcohol
on the myocardium[41,42]. We suggest that these CHD-
subcategories should be included in future longitudinal
analyses as separate end-points. However, it will require
more statistical power which we lacked in the study. We
also emphasize the need for larger population-based stu-
dies from Russia to either replicate or refute our results.
Thus, as a cluster of four major CVD risk predictors,
MetS represents one of the factors contributing to the
high cardiovascular mortality in Russia, but it is unlikely
that it plays a central role at present. Following the
improvements of living conditions during the last dec-
ade, the latest state’s anti-alcohol initiatives launched in
2006, and the recent increase in life-expectancy [43], the
prevalence of MetS is likely to increase in the nearest
future, thereby enhancing the proportion of MetS-
mediated cardiovascular and all-cause deaths in Russia.
Conclusion
Age, GGT and C-reactive protein, and AST-to-ALT
ratio were associated with MetS in both men and
women. High leisure time physical activity in women
and moderate frequency of alcohol consumption and
binge drinking in men were inversely associated with
MetS. Differences between men and women in alcohol
consumption may explain gender variation in the MetS
prevalence. MetS increased the risk of death from stroke
and from either myocardial infarction or stroke during
the 9-year follow-up period in men while no associa-
tions with mortality were found in women.
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